Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
March 25, 2026Cancer Research

Abstract A008: Engineered MHC-I Model as a Novel Platform to Decode the Glioma Immunopeptidome

View Full Paper
Ask AI
Bookmark
Share

Authors

AFAntonio C. Fuentes-FayosASAlberto Ayala SarmientoSPSarah Parker

Discussion

Loading...

Member takes

Overview

Innovative platform decodes glioma immunopeptidomes, enhancing immunotherapy precision for patients.

Key Points

  • This research aims to develop a system for capturing and characterizing the glioma immunopeptidome to identify novel immunotherapeutic targets.
  • Development of a transgenic MHC-I model within MADR glioma models.
  • Utilization of advanced technologies for immunopeptidome capturing and profiling.
  • In vitro and in vivo validation of the new platform.
  • Characterization of differential immunopeptidomes associated with various glioma phenotypes.
  • Successful identification of distinct immunopeptidomes in adult and pediatric gliomas.
  • Revealed unique and shared peptide signatures across different tumor types.
  • Demonstrated potential for the platform to adapt based on tumor evolution and treatment response.

Cite This Study

Fuentes-Fayos et al. (2026) studied this question.

synapsesocial.com/papers/69c37b62b34aaaeb1a67dc0bhttps://doi.org/10.1158/1538-7445.brain26-a008
View Full Paper
Ask AI
Bookmark
Share